Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00502372 · ClinicalTrials.gov registry record · Phase 1
Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)
A Phase 1 study, sponsored by Central Arkansas Veterans Healthcare System.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT00502372 is a Phase 1 study that was terminated before completion, run by Central Arkansas Veterans Healthcare System. The registered enrollment target is 9 participants.
The verdict
NCT00502372, a Phase 1 study, was terminated before completion, sponsored by Central Arkansas Veterans Healthcare System.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The focus of this study is to look at the role of nutrition in the healing of pressure ulcers. The purpose of this study is to test whether the rate of healing of pressure ulcers is increased in those patients receiving a nutritional supplement of amino acids and the leucine metabolite, B-hydroxy-B-methylbutyrate is enhanced when compared to control patients receiving a supplement containing only one of the proteins in the experimental supplement
Interventions
- DIETARY_SUPPLEMENT Juven
- DIETARY_SUPPLEMENT Nutritional Supplement/Amino acids and HMB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00502372
The ClinicalTrials.gov registry entry for NCT00502372 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Central Arkansas Veterans Healthcare System, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Juven is the first listed.
NCT00502372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00502372 about?
NCT00502372 is a clinical study titled "Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)". The focus of this study is to look at the role of nutrition in the healing of pressure ulcers. The purpose of this study is to test whether the rate of healing of pressure ulcers is increased in those patients receiving a nutritional supplement of amino acids and the leucine metabolite, B-hydroxy-B-...
What is the current status of trial NCT00502372?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2008-12. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00502372?
The interventions under investigation include: Juven (DIETARY_SUPPLEMENT), Nutritional Supplement/Amino acids and HMB (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00502372?
This trial is sponsored by Central Arkansas Veterans Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.